Vimarsana
Biggest News Aggregation in the World

Page 2 - Stuart Goldstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stuart Goldstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stuart Goldstein Today - Breaking & Trending Today

AcelRx Pharmaceuticals, Inc. (ACRX) Q3 2022 Results - Earnings Call Transcript - Vimarsana News

AcelRx Pharmaceuticals, Inc. (ACRX) Q3 2022 Results - Earnings Call Transcript

AcelRx Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ACRX) Q3 2022 Results Earnings Conference Call November 14, 2022, 04:30 PM ET Company Participants Raffi Asadorian - Chief Financial Officer...

SeaStar Medical (Nasdaq: ICU) Announces Positive Interim Safety Findings from Ongoing Study Evaluating the Selective Cytopheretic Device (SCD) in Children Seite 1 - Vimarsana News

SeaStar Medical (Nasdaq: ICU) Announces Positive Interim Safety Findings from Ongoing Study Evaluating the Selective Cytopheretic Device (SCD) in Children Seite 1

03.11.2022 - Data being presented at the American Society of Nephrology (ASN) Kidney Week 2022 Interim study data show that SCD treatment is safe to use in pediatric patients with Acute Kidney Injury (AKI) requiring continuous kidney replacement therapy (CKRT) ... Seite 1

AcelRx Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Vimarsana News

AcelRx Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Advanced Niyad™ supply chain development with a focus on obtaining an Emergency Use Authorization in 2023 $0.6 million net revenue in Q2 2022; fifth...

Oracle Adviser On $9.3B NetSuite Deal Denies Ellison Role - Vimarsana News

Oracle Adviser On $9.3B NetSuite Deal Denies Ellison Role

A Moelis & Co. adviser to a special Oracle Corp. board committee that recommended a disputed $9.3 billion acquisition of Netsuite in 2016 testified in Delaware on Friday that the deal emerged from months of negotiations with the seller and without influence from Oracle founder Lawrence J. Ellison.

Source: law360.com
SeaStar Medical Submits Humanitarian Device Exemption Application to FDA for Use of Selective Cytopheretic Device in Children with Acute Kidney Injury - Vimarsana News

SeaStar Medical Submits Humanitarian Device Exemption Application to FDA for Use of Selective Cytopheretic Device in Children with Acute Kidney Injury

20.07.2022 - Application follows successful pilot study demonstrating the SCD was safe with probable clinical benefits for pediatric patientsDENVER, CO and TAMPA, FL, July 20, 2022 (GLOBE NEWSWIRE) - SeaStar Medical, a medical technology company developing ... Seite 1